HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$0.85
Day range
$0.82 - $0.87
Year range
$0.70 - $25.26
Market cap
3.11M USD
Avg Volume
141.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.52M | 30.49% |
Net income | -8.39M | -479.34% |
Net profit margin | — | — |
Earnings per share | -5.13 | 46.89% |
EBITDA | -2.52M | -30.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.07M | -23.16% |
Total assets | 12.27M | -23.50% |
Total liabilities | 11.13M | 140.68% |
Total equity | 1.14M | — |
Shares outstanding | 1.64M | — |
Price to book | 1.24 | — |
Return on assets | -46.76% | — |
Return on capital | -118.83% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -8.39M | -479.34% |
Cash from operations | -2.48M | -24.46% |
Cash from investing | 0.00 | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.48M | -24.46% |
Free cash flow | 4.31M | 194.98% |
About
Founded
2019
Website
Employees
9
